Assenagon Asset Management S.A. Sarepta Therapeutics, Inc. Transaction History

Assenagon Asset Management S.A.

$60.5 Billion
Q2 2025

A detailed history of Assenagon Asset Management S.A. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 867,939 shares of SRPT stock, worth $11.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

867,939

Previous 712,581 21.8%

Holding current value

$11.8 Million

Previous $45.5 Million 67.37%

% of portfolio

0.02%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	BUY	$17.1 - $63.66 $2.66 Million - $9.89 Million	155,358 Added 21.8%	867,939 $14.8 Million
Q1 2025 Apr 15, 2025	BUY	$63.82 - $127.89 $37 Million - $74.2 Million	580,123 Added 437.97%	712,581 $45.5 Million
Q4 2024 Jan 14, 2025	SELL	$104.54 - $137.94 $22.7 Million - $30 Million	-217,594 Reduced 62.16%	132,458 $16.1 Million
Q3 2024 Oct 23, 2024	SELL	$124.33 - $156.75 $1.2 Million - $1.51 Million	-9,644 Reduced 2.68%	350,052 $43.7 Million
Q2 2024 Jul 18, 2024	SELL	$113.33 - $163.85 $8.84 Million - $12.8 Million	-77,994 Reduced 17.82%	359,696 $56.8 Million
Q1 2024 Apr 24, 2024	BUY	$93.7 - $141.53 $5.05 Million - $7.63 Million	53,911 Added 14.05%	437,690 $56.7 Million
Q4 2023 Jan 17, 2024	SELL	$67.31 - $124.76 $3 Million - $5.56 Million	-44,554 Reduced 10.4%	383,779 $37 Million
Q3 2023 Nov 06, 2023	SELL	$102.5 - $123.59 $30.5 Million - $36.8 Million	-297,454 Reduced 40.98%	428,333 $51.9 Million
Q2 2023 Jul 25, 2023	BUY	$106.4 - $157.19 $12.4 Million - $18.3 Million	116,639 Added 19.15%	725,787 $83.1 Million
Q1 2023 Apr 18, 2023	SELL	$117.53 - $155.99 $14.5 Million - $19.2 Million	-123,384 Reduced 16.84%	609,148 $84 Million
Q4 2022 Jan 12, 2023	SELL	$100.86 - $132.13 $40 Million - $52.4 Million	-396,484 Reduced 35.12%	732,532 $94.9 Million
Q3 2022 Oct 27, 2022	BUY	$75.71 - $119.24 $51.9 Million - $81.8 Million	685,845 Added 154.76%	1,129,016 $125 Million
Q2 2022 Jul 27, 2022	SELL	$62.69 - $88.44 $6.76 Million - $9.54 Million	-107,849 Reduced 19.57%	443,171 $33.2 Million
Q1 2022 Apr 25, 2022	BUY	$63.15 - $90.42 $21 Million - $30.1 Million	332,503 Added 152.16%	551,020 $43 Million
Q4 2021 Feb 01, 2022	BUY	$77.28 - $99.42 $16.6 Million - $21.3 Million	214,664 Added 5571.35%	218,517 $19.7 Million
Q3 2021 Oct 19, 2021	BUY	$65.97 - $92.48 $254,182 - $356,325	3,853 New	3,853 $356,000
Q4 2020 Feb 01, 2021	SELL	$125.56 - $178.74 $8.36 Million - $11.9 Million	-66,590 Closed	0 $0
Q3 2020 Oct 07, 2020	BUY	$127.12 - $172.34 $8.46 Million - $11.5 Million	66,590 New	66,590 $9.35 Million
Q1 2020 Apr 17, 2020	SELL	$82.38 - $131.64 $548,897 - $877,117	-6,663 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$76.53 - $135.58 $509,919 - $903,369	6,663 New	6,663 $860,000
Q1 2019 Apr 26, 2019	SELL	$106.67 - $151.68 $1.66 Million - $2.35 Million	-15,522 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$97.32 - $148.76 $1.51 Million - $2.31 Million	15,522 New	15,522 $1.69 Million

Others Institutions Holding SRPT

# of Institutions

500

Shares Held

89.2M

Call Options Held

1.39M

Put Options Held

1.13M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.19B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Sarepta Therapeutics, Inc. Transaction History